True North Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-21,600
Closed -$1.25M 227
2023
Q1
$1.25M Hold
21,600
0.37% 68
2022
Q4
$1.56M Hold
21,600
0.53% 48
2022
Q3
$1.31M Hold
21,600
0.43% 59
2022
Q2
$1.36M Hold
21,600
0.42% 61
2022
Q1
$1.52M Sell
21,600
-43
-0.2% -$2.91K 0.41% 57
2021
Q4
$1.35M Buy
21,643
+5,600
+35% +$351K 0.23% 92
2021
Q3
$990K Hold
16,043
0.19% 106
2021
Q2
$960K Hold
16,043
0.2% 97
2021
Q1
$975K Sell
16,043
-65
-0.4% -$3.59K 0.23% 88
2020
Q4
$756K Sell
16,108
-8,612
-35% -$373K 0.19% 96
2020
Q3
$918K Buy
24,720
+8,077
+49% +$307K 0.27% 78
2020
Q2
$607K Buy
+16,643
New +$579K 0.15% 106

Other funds holding MET

True North Advisors's MET Position: Q2 2023 in Review

True North Advisors sold out of MetLife (MET) in Q2 2023, closing a stake of 21,600 shares — an estimated $1.25M sold.

True North Advisors first reported a position in MET in Q2 2020 and held it in 12 quarters. The position peaked at $1.56M in Q4 2022. 1,171 funds tracked by Wall St. Rank hold MET as of Q2 2023.

  • True North Advisors reported no remaining MetLife position as of Q2 2023 after selling out during the quarter.
  • True North Advisors sold 21,600 MetLife shares in Q2 2023, an estimated $1.25M.
  • True North Advisors first reported a position in MetLife in Q2 2020 and held it in 12 quarters.
  • True North Advisors's MetLife position peaked at $1.56M in Q4 2022.
  • 1,171 funds tracked by Wall St. Rank held MetLife as of Q2 2023.

Based on True North Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.